Editorial: Aryl hydrocarbon hydroxylase inducibility and lung cancer.
D000230:Adenocarcinoma / Q000209:etiology; D000818:Animals; D002273:Carcinogens; D002283:Carcinoma, Bronchogenic / Q000139:chemically induced* / Q000209:etiology*; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D006224:Cricetinae; D000882:Haplorhini; D006801:Humans; D066298:In Vitro Techniques; D008175:Lung Neoplasms / Q000139:chemically induced / Q000209:etiology* / Q000517:prevention & control; D051379:Mice; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D011083:Polycyclic Compounds / Q000009:adverse effects*; D051381:Rats; D012906:Smoke / Q000032:analysis; D012907:Smoking / Q000150:complications*
D002273:Carcinogens; D011083:Polycyclic Compounds; D012906:Smoke; D006899:Mixed Function Oxygenases